Intangible Assets	6 Months Ended
Intangible Assets	Jun. 30, 2026
Intangible Asset, Goodwill and Other [Abstract]
Intangible Assets	Note 2. Intangible Assets Upon receiving PMA from the FDA for the aura6000 System in March 2026, LivaNova reclassified its indefinite-lived IPR&D intangible asset of $112.0 million from the acquisition of ImThera to a finite-lived developed technology intangible asset and commenced amortization over an estimated useful life of 15 years.